PURWANIATI, P.-. Molecular Docking Study on COVID-19 Drug Activity of N-(2-phenylethyl)methanesulfonamide Derivatives as Main Protease Inhibitor. Ad-Dawaa’ Journal of Pharmaceutical Sciences, v. 3, n. 1, 25 Jun. 2020.